AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $544K invested in AIM ImmunoTech in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$62.2K
2
+$60.1K

Top Sellers

1
-$18K
2
-$17.3K
3
-$10.5K
4
Renaissance Technologies
Renaissance Technologies
New York
-$9K
5
Wells Fargo
Wells Fargo
California
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$181K
2
$178K
3
$79K
4
$29K
5
$16K
6
$14K
7
$13K
8
$11K
9
$8K
10
$6K
11
$4K
12
$4K
13
$1K
14
–
15
–
16
–